Minerva Surgical, Inc. (UTRS) News

Minerva Surgical, Inc. (UTRS): $0.00

0.01 (-99.17%)

POWR Rating

Component Grades

Momentum

D

Stability

C

Sentiment

Quality

C

Add UTRS to Watchlist
Sign Up

Industry: Medical - Services

Industry

NR

Ranked

#32 of 85

in industry

Filter UTRS News Items

UTRS News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

Latest UTRS News From Around the Web

Below are the latest news stories about MINERVA SURGICAL INC that investors may wish to consider to help them evaluate UTRS as an investment opportunity.

ADBE Stock Alert: Adobe and Figma Terminate Merger Agreement

Adobe stock is up on Monday as investors in ADBE react to the company calling off its merger plans with Figma due to regulatory reasons.

William White on InvestorPlace | December 18, 2023

Goldman Sachs Is Souring on Nokia (NOK) Stock

Nokia stock is falling on Monday after shares of NOK were hit with a downgrade and lowered price target from Goldman Sachs.

William White on InvestorPlace | December 18, 2023

Why Is Minerva Surgical (UTRS) Stock Down 50% Today?

Minerva Surgical stock is falling hard on Monday after the women's healthcare company announced plans to delist UTRS shares.

William White on InvestorPlace | December 18, 2023

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

It's time to start the week with a breakdown of the biggest pre-market stock movers worth keeping an eye on for Monday morning!

William White on InvestorPlace | December 18, 2023

Minerva Surgical Reports Third Quarter 2023 Financial Results

SANTA CLARA, Calif., Nov. 13, 2023 (GLOBE NEWSWIRE) -- Minerva Surgical, Inc. (Nasdaq: UTRS) (Minerva Surgical or the Company), a women's health company focused on solutions to meet the distinct uterine healthcare needs of women, today reported third quarter financial results for the period ended September 30, 2023. Third Quarter Highlights: Reported revenue of $12.0 million in the third quarter of 2023, compared with revenue of $12.6 million in the third quarter of 2022Increased Symphion produc

Yahoo | November 13, 2023

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

Pre-market stock movers are worth keeping track of and we're helping with the biggest winners and losers for Wednesday morning!

William White on InvestorPlace | September 27, 2023

Minerva Surgical, Inc. (UTRS) Reports Q2 Loss, Misses Revenue Estimates

Minerva Surgical, Inc. (UTRS) delivered earnings and revenue surprises of 44.44% and 3.80%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?

Yahoo | August 2, 2023

Minerva Surgical Reports Second Quarter 2023 Financial Results

SANTA CLARA, Calif., Aug. 02, 2023 (GLOBE NEWSWIRE) -- Minerva Surgical, Inc. (Nasdaq: UTRS) (Minerva Surgical or the Company), a women's health company focused on solutions to meet the distinct uterine healthcare needs of women, today reported second quarter financial results for the period ended June 30, 2023. Second Quarter Highlights: Reported revenue of $13.4 million in the second quarter of 2023, compared with revenue of $13.0 million in the second quarter of 2022Increased both Symphion an

Yahoo | August 2, 2023

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

It's time to start off the trading week with a breakdown of all the biggest pre-market stock movers worth watching on Monday!

William White on InvestorPlace | July 17, 2023

Investors in Minerva Surgical (NASDAQ:UTRS) from a year ago are still down 86%, even after 51% gain this past week

Minerva Surgical, Inc. ( NASDAQ:UTRS ) has rebounded strongly over the last week, with the share price soaring 51%. But...

Yahoo | May 25, 2023


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!